Updated 4:29 p.m., March 18, 2010The cardiac inflammation biomarker developed by Dr. Stanley Hazen and his colleagues at the Cleveland Clinic was a valuable and proven technology, thought Jake Orville, president and chief executive of Cleveland HeartLab.The question: How to take a test for the biomarker to market?Based on Hazen’s research, Cleveland Clinic spin-off company [...]

Updated 4:24 p.m.Cleveland Clinic spinoff Cleveland HeartLab has completed a $3 million fundraising round, and named its executives and advisers.Investors in the round included Glengary LLC, Second Generation Ltd. and Zapis Capital Group LLC, all in Northeast Ohio, according to a company release.Cleveland HeartLab is a clinical reference laboratory specializing in next-generation cardiovascular disease prevention, [...]

The company plans to use the investment to bolster its sales and marketing efforts and expand its laboratory.